Upcoming Webinars

Please note: the webinars listed on this page are hosted by other organizations, so any questions regarding the webinars should be sent to the relevant organization, and not PICNet. Webber Teleclasses are listed on a different page.

Currently scheduled webinars.

  • Friday, April 9, 2021 at 11:00 AM — University of Calgary – The Department of Community Health Sciences and the O’Brien Institute for Public Health present: Is airborne transmission an important and mitigatable aspect of the COVID-19 pandemic? – A panel discussion. Registration details are available here: https://events.ucalgary.ca/obrien/#!view/event/event_id/306929

Recently Archived Webinars

BCCDC Grand Rounds: How to fit a square peg in a round hole: tools for transforming and making sense of whole genome sequencing metadata

Click here for details

Presenters: Dr. Emma Griffiths and Damion Dooley
Date and time: Tuesday Sept 18th,2018, 12:00PM to 1:00PM
Click here for archived webinar

Presenter bios: 

Dr. Emma Griffiths received her PhD from McMaster University in Biochemistry, studying the evolutionary relationships between different groups of bacteria. She has since pursued postdoctoral training in the fields of chemical and fungal genetics. Emma currently is a postdoc at Simon Fraser University co-supervised by Dr. Fiona Brinkman and Dr. Will Hsiao. Her current work focuses on improving genomics contextual data exchange for tuberculosis and foodborne pathogens.

Damion Dooley is a scientific programmer in the Hsiao Public Health Bioinformatics Laboratory, British Columbia Centre for Disease Control, affiliated with the University of British Columbia Department of Pathology and Laboratory Medicine.  Since 2013 he has been a key part of the Genome Canada funded IRIDA.CA project, with a focus on biomedical ontology development in support of rapid enteric pathogen whole genome sequencing and analysis.

Abstract: The ability to share data between groups and organizations is crucial for infectious disease surveillance and investigation. Reliable capture and harmonization of whole genome sequencing (WGS) metadata, or “contextual information” (sample source, experimental and bioinformatics methods, lab, clinical and epidemiological data), is critical for the interpretation of WGS results used for decision making in health crises. The Hsiao lab is currently working on developing computational tools to better harmonize and integrate genomics contextual data into food microbiology and public health workflows. In this talk, we will describe the many uses of these tools – both at the BCCDC, as well as within the wider food safety and public health communities.

BCCDC Grand Rounds: Cytokines and signaling molecules predict clinical outcomes after severe infection in sepsis patients

Click here for details

Presenter: Dr. Chris Fjell
Click here for archived webinar

Speaker bio: Chris Fjell, PhD, is a clinical genomic microbiologist at the Public Health Lab of the BC CDC. Prior to starting at the BC CDC last month, Chris studied pathogen and host response in critical care medicine at St Paul’s hospital (Centre for Heart Lung Innovation, UBC) and UBC department of Microbiology & Immunology, was a staff health data analyst at Vancouver Coastal Health Research Institute (UBC), and staff scientist at the BC Cancer Agency Centre for Clinical Genomics.

Abstract: Sepsis is a life-threatening syndrome following severe infection due to immune response; organ failure occurs despite absence of infection at sites of failing organs. The immune response during sepsis is incompletely understood due to small sample sizes and variable timing of measurements following the onset of symptoms. The vasopressin in septic shock trial (VASST) compared the addition of vasopressin to norepinephrine alone in patients with septic shock. During this study plasma was collected and 39 cytokines measured in a 363 patients at both baseline (before treatment) and 24 hours. Clinical features relating to both underlying health and the acute organ dysfunction induced by the severe infection were collected during the first 28 days of admission. Cluster analysis of cytokines identifies three subgroups of patients at differing risk of death and organ failure; however, these subgroups do not correspond to the infecting pathogen. Depending on the level of immune response as identified by cytokine concentrations, vasopressin offers benefit over norepinephrine alone.

BCCDC Grand Rounds: Bioinformatics activities for genomic sequencing in the Public Health Lab

Click here for details

Date and time: Tuesday, May 1, 12-1 pm
Presenter: Dr. William Hsiao
Click here for archived webinar

Speaker bio: Dr. William Hsiao joined BCCDC Public Health Laboratory in September 2011 as the Lead Bioinformatician. He has established the bioinformatics analysis platforms and services in the PH Lab in the last few years, while conducting research as a Clinical Assistant Professor in the department of Pathology and Laboratory Medicine at UBC. In 2017, he moved into a Senior Scientist position co-funded by the BC Ministry of Agriculture and supports the bioinformatics analysis of both PHL and Animal Health Centre. His current research focuses on developing bioinformatics applications, and using next generation sequencing technologies to study microbial pathogens and microbial communities (microbiomes). He has participated in several genomics and metagenomics projects and is currently leading the effort to develop a bioinformatics platform to use whole genome sequencing to facilitate public health infectious disease outbreak investigations. The other half of his group works on knowledge integration using “ontology” – another topic for another day. Overall, his research aims to improve our understanding of the pathogens that make us sick and the microbiota that keep us healthy.

High throughput sequencing technologies have provided transformative tools for infectious disease surveillance and outbreak investigations. Many research studies have shown the effectiveness of using genomic fingerprinting for tracking transmission and for identifying sources of infection. Yet, the amount of data generated by these sequencers and the complexity of sample and data analytical workflows means routine use of these technologies is still challenging. In this talk, I will discuss some of the software tools and platforms that we have setup at the public health lab to facilitate genomic analysis and to invite others who are interested in our service to discuss their needs with us.

BCCDC Grand Rounds: Options for treating latent TB infection

Click here for details

Presenter: Dr. Victoria Cook
Date and time: Tuesday, April 17, 2018  
Webinar link: Click here to view the archived webinar

Talk Summary/Learning objectives:

  1. Understand the use and limitations of Isoniazid to treat LTBI
  2. Explore “new” options to treat LTBI
  3. Appreciate the programmatic roll-out of LTBI treatment

Speaker bio: Dr. Victoria J Cook has been based at the BC Centre for Disease Control, Division of TB Control since 2002. Dr. Cook is a member of the Respiratory Division at Vancouver General Hospital, is a Clinical Associate Professor in the Faculty of Medicine at UBC, and is the current Training Program Director for UBC Adult Respirology. As physician consultant for the on-reserve TB program (TBSAC), she became particularly interested in the implementation and evaluation of novel strategies to control tuberculosis (TB) in high-risk populations. Ongoing research includes exploring ways to improve LTBI diagnosis and treatment completion in persons at risk for TB. Currently, she is the Medical Head of Provincial TB Services. She provides consultative services to the First Nations Health Authority and the Yukon Government. She continues to provide clinical care in the Provincial TB Clinics and on the TB Ward at VGH. She also supports TB programming across the province and nationally working with partners in the Regional Health Authorities and federal agencies. Dr. Cook is the co-chair of the BC TB Strategic Committee, working to implement the Provincial Strategic Plan for TB Prevention, Treatment and Control. She is also the current President of the North American Region of The Union (International Union against TB and Lung Diseases).

BCCDC Grand Rounds: The Ethics of Antibiotic Stewardship – What is Stewardship and Who is a Steward?

Click here for details

Hosted by: BCCDC
Presenter: Dr. Adrian M. Viens
Date and time: Tuesday, March 27, 2018  12:00 PM PDT
Webinar link

Bio of the speaker: Dr. A.M. Viens is an Associate Professor in Public Health Law at the University of Southampton. He is also Director of the Centre for Health, Ethics and Law (HEAL) and the Public Health Ethics and Law Research Group (PHEL).  His research centres on issues at the intersection of moral, political and legal theory and public policy, with a particular focus on how human behaviour, social conditions and regulation impact health. His current research examines different issues within public health and global health policy, practice and research (especially in relation to communicable disease control, antimicrobial resistance and public health emergencies). He sits on the Health Protection Committee and the Ethics Committee at the UK Faculty of Public Health. He is on the editorial boards of Public Health Ethics, Bioethics and Health Care Analysis, and is also a fellow of the Royal Society of Public Health.

Summary of the talk: With greater awareness of the emergence and spread of antibiotic resistance and the seriousness of its consequences, there has been a concerted push towards antibiotic stewardship. The almost exclusive focus of these stewardship activities, however, has concerned medical and scientific matters. While stewardship certainly involves decision-making and policy-making concerning these technical matters, stewardship also involves decision-making and policy-making concerning matters that are inherently and inescapably ethical. Acting as a steward will often involve making moral judgments, promoting particular values and prioritizing different aims – which are normative, and not technical, activities. This paper will argue we should understand antibiotic stewardship as a normative enterprise (involving the need to clarify how we should understand the concept of stewardship and its values) and the need to understand stewardship as a form of governance. This can help us to better clarify and justify how we should understand the role and responsibilities of antimicrobial stewards. 


BCCDC Grand Rounds Archives

Did you miss a Grand Round that you’d like to have seen?

BCCDC Public Health Grand Rounds and Research Week sessions as of October 2019 are available here

To access the library of archived Grand Rounds and Research Week sessions until July 2019, visit here

BC Patient Safety and Quality Council (BCPSQC) Webinars

There are many archived webinars on the BCPSQC website.